Contract Manufacturing, Finished Drug Product

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

Fresenius Kabi will add to its generic, sterile injectable manufacturing at its Melrose Park, Illinois site.

Stability testing programs should provide drug owners the information needed to establish the proper handling, shipping, and shelf-life recommendations for drug products.

The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.

The company expanded its services to include oligonucleotide API development and manufacturing and received approval for its Caponago manufacturing facility.

A RoTab tablet press can product up to 42,000 tablets per hour for Juniper Pharma Services.

The company expanded its topicals capacity with an investment in the Becomix RW30 model homogenizer.

For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.

In the past, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) have been focused most on achieving scale, reaching new clients in new geographic regions, and adding services that were previously unavailable, according to Gil Y. Roth, president of the Pharma and Biopharma Outsourcing Association. In a new report from CPhI, Roth explicates how consolidation has changed how CMOs position their services to clients and how CMOs add value to their businesses.

Vetter plans to invest approximately 300 million Euros during the course of five years to expand drug product manufacturing and logistic services in Germany; upgrades will include an improved RABS system for aseptic processing.

While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.

The 12th Annual Report and Survey of Biomanufacturing is now available.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Is there enough talent to go around?

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.